OI

Oakbrook Investments Portfolio holdings

AUM $39.2M Turnover 87.07%
1-Year Est. Return 3.66%
This Fund
S&P 500
This Quarter Est. Return
+8.78%
1 Year Est. Return
-3.66%
3 Year Est. Return
+26.09%
5 Year Est. Return
+53.43%
10 Year Est. Return
–
AUM
$1.8B
AUM Growth
+$220M
Cap. Flow
+$92.2M
Cap. Flow %
5.11%
Top 10 Hldgs %
23.35%
Holding
698
New
144
Increased
374
Reduced
112
Closed
60
Avg Time Held
2.1 years
Top 10 Avg Time Held
1.1 years
Top 20 Avg Time Held
2.7 years

Top Buys

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$23M
2
MDLZ icon
Mondelez International
MDLZ
+$11.8M
3
GIS icon
General Mills
GIS
+$11.6M
4
JNJ icon
Johnson & Johnson
JNJ
+$8.36M
5
CRM icon
Salesforce
CRM
+$5.1M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$23.4M
2
V icon
Visa
V
+$13.3M
3
ADSK icon
Autodesk
ADSK
+$10.2M
4
PEP icon
PepsiCo
PEP
+$9.62M
5
ORCL icon
Oracle
ORCL
+$6.9M

Sector Composition

Rank Sector Weight
1 Healthcare 17.33%
2 Technology 16.65%
3 Financials 15.24%
4 Consumer Discretionary 11.43%
5 Industrials 11.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
AAPL icon
1
Apple
AAPL
$5.01T
$63.6M 3.53%
1,126,504
-58,056
-5% -$3.02M
2013 Q2
21 quarters
NKE icon
2
Nike
NKE
$52.4B
$43.9M 2.44%
518,760
+17,149
+3% +$1.38M
2013 Q2
21 quarters
MDT icon
3
Medtronic
MDT
$121B
$41.8M 2.32%
425,135
-24,421
-5% -$2.26M
2013 Q2
21 quarters
V icon
4
Visa
V
$735B
$41.1M 2.28%
274,098
-93,259
-25% -$13.3M
2013 Q2
21 quarters
ADSK icon
5
Autodesk
ADSK
$48.3B
$40.3M 2.24%
258,309
-72,245
-22% -$10.2M
2013 Q2
21 quarters
MRK icon
6
Merck
MRK
$364B
$40M 2.22%
590,442
-36,016
-6% -$2.29M
2013 Q2
21 quarters
CAT icon
7
Caterpillar
CAT
$344B
$39.6M 2.2%
259,798
-15,669
-6% -$2.22M
2013 Q2
21 quarters
DIS icon
8
Walt Disney
DIS
$188B
$39.6M 2.2%
338,690
-16,817
-5% -$1.87M
2013 Q2
21 quarters
AMGN icon
9
Amgen
AMGN
$230B
$35.5M 1.97%
171,426
-30,363
-15% -$5.98M
2013 Q2
21 quarters
CME icon
10
CME Group
CME
$103B
$35.5M 1.97%
208,565
-12,433
-6% -$2.09M
2013 Q2
21 quarters
MSFT icon
11
Microsoft
MSFT
$3.96T
$35.2M 1.95%
307,622
+400
+0.1% +$43.4K
2013 Q2
21 quarters
GOOGL icon
12
Alphabet (Google) Class A
GOOGL
$4.25T
$35M 1.94%
580,200
+7,000
+1% +$424K
2015 Q4
11 quarters
SBUX icon
13
Starbucks
SBUX
$106B
$34.6M 1.92%
608,265
-35,849
-6% -$1.9M
2015 Q1
14 quarters
AMZN icon
14
Amazon
AMZN
$2.74T
$33.9M 1.88%
338,580
-13,500
-4% -$1.27M
2013 Q2
21 quarters
MKC icon
15
McCormick & Company Non-Voting
MKC
$12.1B
$32.6M 1.81%
494,718
-30,100
-6% -$1.86M
2014 Q1
18 quarters
VAR
16
DELISTED
Varian Medical Systems, Inc.
VAR
$31.5M 1.75%
281,196
-49,852
-15% -$5.64M
2016 Q2
9 quarters
PEP icon
17
PepsiCo
PEP
$176B
$30.6M 1.7%
273,976
-84,946
-24% -$9.62M
2013 Q2
21 quarters
MMM icon
18
3M
MMM
$84.8B
$26.4M 1.46%
149,732
-30,113
-17% -$5.19M
2013 Q2
21 quarters
QCOM icon
19
Qualcomm
QCOM
$184B
$24.7M 1.37%
343,306
-24,150
-7% -$1.59M
2013 Q2
21 quarters
GOOG icon
20
Alphabet (Google) Class C
GOOG
$4.2T
$23.4M 1.3%
392,920
-28,580
-7% -$1.71M
2013 Q2
21 quarters
CL icon
21
Colgate-Palmolive
CL
$74B
$23.2M 1.28%
+345,909
New +$23M
2018 Q3
0 quarters
SLB icon
22
SLB Ltd
SLB
$72B
$21.2M 1.17%
347,474
-27,596
-7% -$1.78M
2013 Q2
21 quarters
JCI icon
23
Johnson Controls International
JCI
$92.3B
$19.3M 1.07%
552,632
-33,203
-6% -$1.22M
2015 Q1
14 quarters
META icon
24
Meta Platforms (Facebook)
META
$1.88T
$17.5M 0.97%
106,642
+2,150
+2% +$389K
2013 Q2
21 quarters
BIIB icon
25
Biogen
BIIB
$34.4B
$17.4M 0.97%
49,305
+1,374
+3% +$473K
2013 Q2
21 quarters
1
2 3 4 5

Similar funds

MF
MHI Funds Woodstock, New York $34.7M AUM 17.93% 1-Year Est. Return
AIM
Act II Management New York $33.8M AUM 8.86% 1-Year Est. Return
QCMA
Quad Capital Management Advisors New York $31.4M AUM 22.55% 1-Year Est. Return
SC
Salzman & Co Pittsford, New York $29.7M AUM 12.12% 1-Year Est. Return
BIM
Beach Investment Management West Conshohocken, Pennsylvania $28.8M AUM 11.57% 1-Year Est. Return
GP
Gresham Partners Chicago, Illinois $26.2M AUM 18.05% 1-Year Est. Return
GAM
GQ Asset Management New York City, New York $52.7M AUM 8.84% 1-Year Est. Return
SCM
Shoals Capital Management Arlington, Virginia $21.5M AUM 38.8% 1-Year Est. Return

Oakbrook Investments's Q3 2018 Portfolio in Review

As of Q3 2018, Oakbrook Investments held 698 positions worth $1.8B, up 14% from $1.58B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Oakbrook Investments deployed $92.2M of net new capital in Q3 2018, opening 144 new positions and adding to 374 existing holdings. Its largest new stake was Colgate-Palmolive: 345,909 shares worth $23.2M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $23.4M trimmed.

  • Oakbrook Investments's largest Q3 2018 buy was Colgate-Palmolive: 345,909 shares worth $23.2M.
  • Oakbrook Investments added most to Mondelez International in Q3 2018, an estimated $11.8M increase.
  • Oakbrook Investments's biggest Q3 2018 reduction was Gilead Sciences, cutting an estimated $23.4M.
  • Oakbrook Investments fully exited CSX Corp in Q3 2018, selling an estimated $3.83M.
  • Oakbrook Investments's ten largest holdings make up 23% of its $1.8B portfolio in Q3 2018.
  • Oakbrook Investments opened 144 new positions and closed 60 in Q3 2018.
  • Oakbrook Investments's portfolio value rose 14% quarter-over-quarter to $1.8B.

Based on Oakbrook Investments's 13F filing for Q3 2018, filed 18 Oct 2018.